|
Volumn 78, Issue 4, 1998, Pages 489-
|
Can acipimox reduce serum lipoprotein(a) levels in hemodialyzed patients? [1]
a a a
a
NONE
(Greece)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACIPIMOX;
LIPOPROTEIN A;
ADULT;
AGED;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HEMODIALYSIS;
HUMAN;
HYPERLIPOPROTEINEMIA;
LETTER;
LIPOPROTEIN BLOOD LEVEL;
MALE;
PRIORITY JOURNAL;
AGED;
ANTILIPEMIC AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
LIPOPROTEIN(A);
MALE;
MIDDLE AGED;
PYRAZINES;
RENAL DIALYSIS;
|
EID: 0031979718
PISSN: 00282766
EISSN: None
Source Type: Journal
DOI: 10.1159/000044980 Document Type: Letter |
Times cited : (1)
|
References (4)
|